Using the WHOQOL-DIS to measure quality of life in persons with physical disabilities caused by neurodegenerative disorders

Neurodegenerative Diseases

Volumn 8, Issue 4, 2011, Pages 178-186

  Lucas Carrasco, Ramona ^a,e   Pascual Sedano, Berta ^b   Galán, Ingrid ^c   Kulisevsky, Jaime ^b   Sastre Garriga, Jaume ^d   Gómez Benito, Juana ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Unitat de Neurorehabilitació ^*  (Spain)

^d Centre d'Esclerosi Múltiple de Catalunya CEM Cat   (Spain)

^e CRE Alzheimer Salamanca   (Spain)

Author keywords

Neurodegenerative disorders; Quality of life; Reliability; Self assessment; Validity evidence; World Health Organization Quality of Life Disability (WHOQOL DIS); World Health Organization Quality of Life Questionnaire (WHOQOL BREF)

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEGENERATIVE DISEASE; DEPRESSION; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PHYSICAL DISABILITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SELF EVALUATION; SOCIAL ASPECT; VALIDITY; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; WORLD HEALTH ORGANIZATION;

EID: 79955872870     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000321582     Document Type: Article

References (41)

1. Atlas: Country Resources for Neurological Disorders 2004. Geneva, World Health Organization, 2004.
2. De Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535. (Pubitemid 44262284)
3. Koutsouraki E, Costa V, Baloyannis S: Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010; 22: 2-13.
4. Schestatsky P, Zanatto VC, Margis R, Chachamovich E, Reche M, Batista RG, Fricke D, Rieder CR: Quality of life in a Brazilian sample of patients with Parkinson's disease and their caregivers. Rev Bras Psiquiatr 2006; 28: 209-211. (Pubitemid 44506526)
5. Aymerich M, Guillamón I, Jovell AJ: Healthrelated quality of life assessment in people with multiple sclerosis and their family caregivers. A multi-center study in Catalonia (Southern Europe). Patient Prefer Adherence 2009; 3: 311-321.
6. Schrag A, Jahanshahi M, Quinn N: How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000; 15: 1112-1118.
7. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G: Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008; 23: 1420-1427.
8. McCabe MP: Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 2005; 59: 161-166. (Pubitemid 41383600)
9. Wynia K, Middel B, De Ruiter H, Van Kijk JP, Lok WS, De Keyser JH, Reijneweld SA: Adding a subjective dimension to an ICF-based disability measure for people with multiple sclerosis: development and use of a measure for perception of disabilities. Disabil Rehabil 2009; 31: 1008-1017.
10. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L: Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001; 7: 340-344. (Pubitemid 33026260)
11. The WHOQOL Group: The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-1409.
12. The WHOQOL Group: The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46: 1569-1585.
13. Power MJ, Green AM, WHOQOL-Dis Group: Development of the WHOQOL disabilities module. Qual Life Res 2010; 19: 571-584.
14. Lucas-Carrasco R: La versión española del WHOQOL. Madrid, Ergón, 1998.
15. Bech P, Lucas R, Amir M, Bushnell M, Martin M, Buesching D; LIDO Group: Association between clinically depressed subgroups, type of treatment and patient retention in the LIDO study. Psychol Med 2003; 33: 1051-1059. (Pubitemid 37009823)
16. Simon GE, Fleck M, Lucas R, Bushnell DM; LIDO Group: Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004; 161: 1626-1634. (Pubitemid 39201460)
17. Lucas-Carrasco R: International perspective on quality of life in older adults. The WHOQOL OLD project. Vertex 2007; 18: 130-137.
18. Wynia K, Middel B, van Dijk JP, De Keyser JH, Reijneveld SA: The impact of disabilities on quality of life in people with multiple sclerosis. Mult Scler 2008; 14: 972-980.
19. Damiano AM, Snyder C, Strausser B, William MK: A review of health-related qualityof-life concepts and measures for Parkinson's disease (review). Qual Life Res 1999; 8: 235-243. (Pubitemid 29367292)
20. Hirayama MS, Gobbi S, Gobbi LT, Stella F: Quality of life (QoL) in relation to disease severity in Brazilian Parkinson's patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr 2008; 46: 147-160. (Pubitemid 351217079)
21. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
22. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
23. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group: The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004; 13: 299-310. (Pubitemid 38392258)
24. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R: The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248.
25. Peto V, Jenkinson C, Fitzpatrick R: PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245(suppl 1):S10-S14. (Pubitemid 28230759)
26. Martínez-Martín P, Frades PB: Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol 1998; 245(suppl 1):S34-S38. (Pubitemid 28230765)
27. Hobart JC, Lamping DL, Fitzpatrick R, et al: The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-973. (Pubitemid 32458508)
28. Michielsen HJ, De Vries J, Van Heck GL: Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 2003; 54: 345-352. (Pubitemid 38365998)
29. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370. (Pubitemid 13098606)
30. Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ: Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002; 25: 318-324. (Pubitemid 36025272)
31. Rodriguez-Blazquez C, Frades-Payo B, Forjaz MJ, de Pedro-Cuesta J, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study Group: Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease. Mov Disord 2009; 24: 519-525.
32. Diener E, Emmons RA, Larsen RJ, Griffin S: The Satisfaction With Life Scale. J Pers Assess 1985; 49: 71-75. (Pubitemid 15080385)
33. Atienza FL, Pons D, Balaguer I, García-Merita M: Propiedades psicométricas de la escala de satisfacción con la vida en adolescentes. Psicothema 2000; 12: 314-320.
34. McHorney CA, Tarlov AR: Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.
35. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
36. Kline P: Personality: Measurement and Theory. London, Hutchinson, 1983.
37. Ueda S, Okawa Y: The subjective dimension of functioning and disability: what is it and what is it for? Disabil Rehabil 2003; 25: 596-601. (Pubitemid 36806193)
38. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García- Sánchez C, Gironell A; for the Trapecio Group Study: Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008; 23: 1889-1896.
39. Carod-Artal FJ, Ziomkowski S, Mourão Mesquita H, Martínez-Martin P: Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. Parkinsonism Relat Disord 2008; 14: 102-108. (Pubitemid 351726306)
40. Honarmand K, Feinstein A: Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 2009; 15: 1518-1524.
41. Lucas-Carrasco RL, Lamping DL, Banerjee S, Rejas J, Smith S, Gómez-Benito J: Validation of the Spanish version of the DEMQOL system. Int Psychogeriatr 2010; 22: 589-597.